US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,646 | -1,974 | -980 | -2,891 | -2,301 |
| Depreciation Amortization | 467 | 310 | 147 | 447 | 309 |
| Accounts receivable | -43 | -42 | -53 | -6 | 27 |
| Accounts payable and accrued liabilities | 44 | 54 | -68 | 150 | 79 |
| Other Working Capital | 0 | 17 | -123 | 141 | 115 |
| Other Operating Activity | 1,337 | 999 | 760 | 1,680 | 1,413 |
| Operating Cash Flow | $-841 | $-635 | $-318 | $-479 | $-358 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 839 | 779 | 743 | 543 | 479 |
| Debt Repayment | N/A | N/A | N/A | N/A | -40 |
| Common Stock Issued | 50 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -36 | -24 | 0 | -46 | 0 |
| Financing Cash Flow | $853 | $755 | $743 | $498 | $439 |
| Beginning Cash Position | 19 | 19 | 19 | N/A | N/A |
| End Cash Position | 30 | 138 | 444 | 19 | 81 |
| Net Cash Flow | $12 | $119 | $426 | $19 | $81 |
| Free Cash Flow | |||||
| Operating Cash Flow | -841 | -635 | -318 | -479 | -358 |
| Free Cash Flow | -841 | -635 | -318 | -479 | -358 |